about
Recombinant vacuolar iron transporter family homologue PfVIT from human malaria-causing Plasmodium falciparum is a Fe(2+)/H(+)exchangerTopotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancers.Upper extremity deep vein thrombosis associated with indwelling peripheral venous catheters in gynecology oncology patients.Signature pathways identified from gene expression profiles in the human uterine cervix before and after spontaneous term parturition.Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complicatThe genomic 'inner fish' and a regulatory enigma in the vertebrates.Stable isotope labelling methods in mass spectrometry-based quantitative proteomics.The transcriptome of the uterine cervix before and after spontaneous term parturition.Inductively Coupled Plasma Mass Spectrometry (ICP-MS) Applications in Quantitative Proteomics.A statewide survey of high-support services for people with chronic mental illness: assessment of needs for care, level of functioning and satisfaction.Löffler syndrome on a Louisiana pig farm.Cardiac output is not related to the slowed O2 uptake kinetics in type 2 diabetes.Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades.Lewis A Barness annual lecture: juvenile diabetes revisited.Development and validation of an ICP-MS method for the determination of elemental impurities in TP-6076 active pharmaceutical ingredient (API) according to USP 〈232〉/〈233〉.Radiation therapy with or without chemotherapy for cervical cancer with periaortic lymph node metastasis.An evaluation of the relationships between catheter design and tissue mechanics in achieving high-flow convection-enhanced delivery.Activation of the Bile Acid Pathway and No Observed Antimicrobial Peptide Sequences in the Skin of a Poison FrogOral insulin therapy to prevent progression of immune-mediated (type 1) diabetes
P50
Q30045613-995EC63E-695C-49F7-9D08-0DC082348E1AQ33379265-AC9036F0-A818-4FF0-9CDE-5FFBBCF2CBEDQ35114317-5DF0A9A4-BF7C-4981-867C-4D3C8718AC39Q36915100-89965F51-316F-4D93-9A40-DCF9E3BBA11FQ37054987-729E9327-D8C5-48DA-A742-C862FA12B1CAQ37209985-7EED7F14-4D2A-440A-A3BF-EBE54F28A131Q38468333-7FD98382-49D6-4F6F-9DB4-C62A4CBC290FQ38517760-BB89EF48-C511-41F1-BE25-1430C0A37B32Q39037753-5C2685BF-40E5-41A4-AEF3-0DCFCA292D42Q39694745-DBA73DD4-D794-4F5C-B1A2-BF85442EFE0AQ40086208-F5506A6C-2B7B-445F-9CD0-17B2C8C94668Q44948565-3EEDEEEF-E999-4D6A-9504-EDB32A700797Q46792064-DFA4E871-343D-4B91-B6DA-CD63ECAB35DAQ48545906-56C35774-6B78-47AE-9233-C5F48B5A252FQ48627559-EDDF0D18-FB7D-46FF-BCB8-11D435E186A4Q49285607-809E3E0E-18A4-476A-9F14-EB0F1F1ED828Q52610765-98F56E4C-41EF-4C20-993A-C32F69B36826Q64271773-2332B845-A735-4BD8-B5ED-CA6C2B8789A5Q81341620-CDE22772-34DF-4976-8427-4B734D853873
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
John Malone
@ast
John Malone
@en
John Malone
@es
John Malone
@nl
type
label
John Malone
@ast
John Malone
@en
John Malone
@es
John Malone
@nl
altLabel
John H. Malone
@en
prefLabel
John Malone
@ast
John Malone
@en
John Malone
@es
John Malone
@nl
P1960
09eqGzIAAAAJ
P21
P31
P496
0000-0003-1369-3769